ArticleRadiology case reports2026
Reconsidering pancreatic masses: A case of IgG4-related autoimmune pancreatitis mimicking malignancy.
Article in Radiology case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Autoimmune pancreatitis (AIP) is an uncommon, immune-mediated form of chronic pancreatitis characterized by lymphoplasmacytic infiltration, fibrosis, and frequently elevated serum IgG4 levels. Clinically and radiologically, AIP often mimics pancreatic ductal adenocarcinoma, posing a substantial diagnostic challenge that risks unnecessary surgical interventions. This article presents the case of a 53-year-old female patient with epigastric pain, obstructive jaundice, and a pancreatic head mass initially suggestive of malignancy. Detailed imaging (CT, MRI, MRCP), serological evaluation showing elevated IgG4, and a favorable response to corticosteroid therapy confirmed the diagnosis of type 1 AIP. The case underscores the importance of accurately differentiating AIP from pancreatic malignancies by integrating clinical data, imaging features-particularly the absence of significant double-duct dilatation characteristic of pancreatic cancer-the presence of renal lesions, which represent an unusual metastatic site in pancreatic malignancies, serological markers, histopathological findings, and steroid responsiveness. Early diagnosis is crucial to avoid unwarranted surgery, initiate appropriate immunosuppressive treatment, and ensure favorable long-term outcomes. This report contributes to the growing body of evidence highlighting AIP's diagnostic complexity and underscores the necessity for a multidisciplinary approach in its management.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.